One has to wonder who checks the costing that Novartis uses to justify the price of its Kymriah Cancer Drug. What would Robert Koch, Louis Pasteur or Alexander Fleming make of this behaviour?
https://www.bloomberg.com//news/articles/2017-08-30/cancer-breakthrough-heralds-new-era-of-cures-costs-and-choices
Trump Touts “78 Percent Reduction in the Trade Deficit” Due to Tariffs
-
Let's compare Trump's claim to actual trade numbers.
4 hours ago
No comments:
Post a Comment